Diffusion Pharmaceuticals is a biotechnology business based in the US. Diffusion Pharmaceuticals shares (DFFN) are listed on the NASDAQ and all prices are listed in US Dollars. Diffusion Pharmaceuticals employs 13 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Diffusion Pharmaceuticals stock
How to buy Diffusion Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DFFN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Diffusion Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Diffusion Pharmaceuticals stock price (NASDAQ: DFFN)
Use our graph to track the performance of DFFN stocks over time.Diffusion Pharmaceuticals shares at a glance
Latest market close | $9.25 |
---|---|
52-week range | $4.28 - $9.26 |
50-day moving average | $5.06 |
200-day moving average | $7.07 |
Wall St. target price | $40.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-7.11 |
Is it a good time to buy Diffusion Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Diffusion Pharmaceuticals price performance over time
Historical closes compared with the close of $9.25 from 2023-10-18
1 week (2024-07-15) | N/A |
---|---|
1 month (2024-06-22) | N/A |
3 months (2024-04-22) | N/A |
6 months (2024-01-22) | N/A |
1 year (2023-07-26) | 193.65% |
---|---|
2 years (2022-07-26) | 27.94% |
3 years (2021-07-26) | 1,612.96% |
5 years (2019-07-26) | 324.31% |
Diffusion Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -38.24% |
Return on equity TTM | -63.96% |
Profit margin | 0% |
Book value | $6.97 |
Market Capitalization | $9 million |
TTM: trailing 12 months
Diffusion Pharmaceuticals share dividends
We're not expecting Diffusion Pharmaceuticals to pay a dividend over the next 12 months.
Have Diffusion Pharmaceuticals's shares ever split?
Diffusion Pharmaceuticals's shares were split on a 2:3 basis on 16 August 2023. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Diffusion Pharmaceuticals shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for Diffusion Pharmaceuticals shares which in turn could have impacted Diffusion Pharmaceuticals's share price.
Diffusion Pharmaceuticals share price volatility
Over the last 12 months, Diffusion Pharmaceuticals's shares have ranged in value from as little as $4.28 up to $9.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Diffusion Pharmaceuticals's is 1.7645. This would suggest that Diffusion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Diffusion Pharmaceuticals overview
Diffusion Pharmaceuticals Inc. , a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia. .
Frequently asked questions
nullWhat percentage of Diffusion Pharmaceuticals is owned by insiders or institutions?
Currently 0.231% of Diffusion Pharmaceuticals shares are held by insiders and 10.272% by institutions. How many people work for Diffusion Pharmaceuticals?
Latest data suggests 13 work at Diffusion Pharmaceuticals. When does the fiscal year end for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals's fiscal year ends in December. Where is Diffusion Pharmaceuticals based?
Diffusion Pharmaceuticals's address is: 300 East Main Street, Charlottesville, VA, United States, 22902 What is Diffusion Pharmaceuticals's ISIN number?
Diffusion Pharmaceuticals's international securities identification number is: US2537484048 What is Diffusion Pharmaceuticals's CUSIP number?
Diffusion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 253748404
More guides on Finder
-
Best brokerage accounts for index funds [July 2024]
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
-
Options trading strategies for beginners
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question